160 related articles for article (PubMed ID: 7693237)
1. [Effect of preparation and preservation modality on thrombocyte quality].
Mohren M; Müller H; Körner K; Wiesneth M; Kubanek B; Heimpel H; Seifried E
Beitr Infusionsther; 1993; 31():107-10. PubMed ID: 7693237
[TBL] [Abstract][Full Text] [Related]
2. Preparation, storage and quality control of platelet concentrates.
Tynngård N
Transfus Apher Sci; 2009 Oct; 41(2):97-104. PubMed ID: 19699153
[TBL] [Abstract][Full Text] [Related]
3. [Platelet membrane glycoproteins in thrombocytapheresis and platelet concentrates].
Dittmann J; Riggert J; Wieding JU; Simson G; Köhler M
Beitr Infusionsther Transfusionsmed; 1994; 32():422-7. PubMed ID: 9480137
[TBL] [Abstract][Full Text] [Related]
4. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
Bux J; Müller K; Misterek J; Mueller-Eckhardt C
Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
[TBL] [Abstract][Full Text] [Related]
5. Activation of platelet concentrate during preparation and storage.
Rinder HM; Snyder EL
Blood Cells; 1992; 18(3):445-56; discussion 457-60. PubMed ID: 1283703
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of platelet quality obtained using conventional methods or from buffy-coat and stored at room temperature].
Dzieciatkowska A; Fuskiewicz M; Ziemba-Zółowska B; Sabliński J
Acta Haematol Pol; 1994; 25(2):135-43. PubMed ID: 8067184
[TBL] [Abstract][Full Text] [Related]
7. A critical comparison of platelet preparation methods.
Vassallo RR; Murphy S
Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
[TBL] [Abstract][Full Text] [Related]
8. [Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates].
Chakroun T; Abdelkefi S; Bouslama M; Houissa B; Zaier M; Miled A; Kortas M; Yacoub S
Transfus Clin Biol; 2008 Sep; 15(4):148-53. PubMed ID: 18760949
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
10. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
Vasconcelos E; Figueiredo AC; Seghatchian J
Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
[TBL] [Abstract][Full Text] [Related]
11. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
12. Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system.
Gulliksson H; Sjödin A; Sandgren P; Vesterinen M; Larsson S; Diedrich B
Transfus Apher Sci; 2003 Aug; 29(1):11-2. PubMed ID: 12877886
[No Abstract] [Full Text] [Related]
13. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
14. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
Torretta L; Perotti C; Pedrazzoli P; Dornini G; Viarengo G; Livraghi A; Noris P; Da Prada GA; Balduini CL; della Cuna GR; Salvaneschi L
Vox Sang; 1998; 75(3):224-9. PubMed ID: 9852411
[TBL] [Abstract][Full Text] [Related]
15. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
16. [Use and preparation of thrombocyte concentrates].
Jovanović R; Erceg S; Rakić S
Med Pregl; 1996; 49(7-8):301-4. PubMed ID: 8926948
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of thrombocyte concentrates from buffy coats after 3 and 16 hours of storage].
Häberle H; Schulzki T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():73-7. PubMed ID: 9480161
[TBL] [Abstract][Full Text] [Related]
18. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
19. Decreased platelet aggregation of platelet concentrate during storage recovers in the body after transfusion.
Miyaji R; Sakai M; Urano H; Nakata K; Sakamoto H; Shirahata A
Transfusion; 2004 Jun; 44(6):891-9. PubMed ID: 15157257
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Impact-R for monitoring the platelet storage lesion.
Albanyan AM; Murphy MF; Harrison P
Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
